Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome
|
0.310 |
Biomarker
|
disease |
CTD_human |
In SAPHO syndrome, the activation of the PSTPIP2 inflammasome has been suggested to play a role in inducing the dysfunction of the innate immune system.
|
27106250 |
2016 |
Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We analyzed the PSTPIP2 gene in patients with SAPHO syndrome.
|
20032092 |
2010 |
Chronic multifocal osteomyelitis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Chronic recurrent multifocal osteomyelitis (CRMO) in humans can be modeled in <i>Pstpip2<sup>cmo</sup></i> mice, which carry a missense mutation in the proline-serine-threonine phosphatase-interacting protein 2 (<i>Pstpip2</i>) gene.
|
31719149 |
2020 |
Chronic multifocal osteomyelitis
|
0.040 |
Biomarker
|
disease |
BEFREE |
New discoveries in CRMO: IL-1β, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice.
|
25894861 |
2015 |
Chronic multifocal osteomyelitis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
The genes responsible for Majeed syndrome (LPIN2), murine chronic multifocal osteomyelitis (pstpip2), and cherubism (SH3BP2 and possibly PTPN11) have been identified.
|
17762617 |
2007 |
Chronic multifocal osteomyelitis
|
0.040 |
Biomarker
|
disease |
BEFREE |
The roles played by LPIN2 and the human homolog of pstpip2, PSTPIP2, in the etiology of chronic recurrent multifocal osteomyelitis are uncertain but are currently being investigated.
|
17496555 |
2007 |
Osteomyelitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Past discoveries identified several single gene defects (LPIN2, Pstpip2 and IL1RN) that cause IL-1-mediated sterile multifocal osteomyelitis.Recently Lorden et al.
|
29912021 |
2018 |
Inflammatory disorder
|
0.020 |
Biomarker
|
group |
BEFREE |
Proline-serine-threonine phosphatase interacting protein 2 (PSTPIP2) is an adaptor protein, which is associated with auto-inflammatory disease.
|
30564127 |
2018 |
Osteomyelitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
This addendum reviews the current literature on the Pstpip2<sup>cmo</sup> murine disease model and the clinical significance of the role of PSTPIP2 in regulating autoinflammatory osteomyelitis, which is mediated by innate components of immune cells.
|
27148834 |
2016 |
Inflammatory disorder
|
0.020 |
Biomarker
|
group |
BEFREE |
Thus, our data uncover a previously unappreciated antagonism between different F-BAR domain assemblies that determines the threshold of actin polymerization for the formation of functional podosomes and may explain how the absence of PSTPIP2 causes auto-inflammatory disorder.
|
23525018 |
2013 |
Majeed syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
In a cohort of 38 patients with SAPHO we analyzed PSTPIP2 and 2 other candidate genes, NOD2/CARD15 (Crohn's disease occurs in about 10% of SAPHO patients), and LPIN2 (clinical similarities of SAPHO with Majeed syndrome).
|
20032092 |
2010 |
Majeed syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The genes responsible for Majeed syndrome (LPIN2), murine chronic multifocal osteomyelitis (pstpip2), and cherubism (SH3BP2 and possibly PTPN11) have been identified.
|
17762617 |
2007 |
Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We showed that administration of AAV-PSTPIP2 before arthritis onset significantly reduces the severity of AIA.
|
31325437 |
2019 |
Osteopenia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
AIA rats were found to have decreased PSTPIP2 expression and AIA-associated bone loss and inflammatory infiltration.
|
31325437 |
2019 |
Fibrosis, Liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
We further investigated the function of PSTPIP2 in HF by hepatic-adeno-associated virus (AAV9)-PSTPIP2 overexpression.
|
29993036 |
2018 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The present study indicated that APH1B, JAM3, FBLN2, CSAD and PSTPIP2 may have important roles in the progression of atherosclerosis in females and may be potential biomarkers for early diagnosis and prognosis as well as treatment targets for this disease.
|
27573188 |
2016 |
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The present study indicated that APH1B, JAM3, FBLN2, CSAD and PSTPIP2 may have important roles in the progression of atherosclerosis in females and may be potential biomarkers for early diagnosis and prognosis as well as treatment targets for this disease.
|
27573188 |
2016 |
Autoinflammatory disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
A leucine-to-proline missense mutation at residue 98 in the proline-serine-threonine phosphatase interacting protein 2 (Pstpip2) gene leads to autoinflammatory disease that is characterized by splenomegaly, necrosis, and spontaneous development of osteomyelitis in mice (Pstpip2<sup>cmo</sup>).
|
27148834 |
2016 |
Cherubism
|
0.010 |
Biomarker
|
disease |
BEFREE |
The genes responsible for Majeed syndrome (LPIN2), murine chronic multifocal osteomyelitis (pstpip2), and cherubism (SH3BP2 and possibly PTPN11) have been identified.
|
17762617 |
2007 |